Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2
fusion detected by a liquid comprehensive genomic profiling test
- Shun Ishido
, - Nobuharu Tamaki,
- Kento Inada,
- Jun Itakura,
- Yuka Takahashi,
- Naoki Uchihara,
- Keito Suzuki,
- Yuki Tanaka,
- Haruka Miyamoto,
- Michiko Yamada,
- Hiroaki Matsumoto,
- Tsubasa Nobusawa,
- Taisei Keitoku,
- Kenta Takaura,
- Shohei Tanaka,
- Chiaki Maeyashiki,
- Yutaka Yasui,
- Kaoru Tsuchiya,
- Hiroyuki Nakanishi,
- Masayuki kurosaki,
- Namiki Izumi
02 May 2023Submitted to Clinical Case Reports 03 May 2023Submission Checks Completed
03 May 2023Assigned to Editor
08 May 2023Reviewer(s) Assigned
23 May 2023Review(s) Completed, Editorial Evaluation Pending
24 May 2023Editorial Decision: Revise Minor
03 Jun 20231st Revision Received
06 Jun 2023Submission Checks Completed
06 Jun 2023Assigned to Editor
06 Jun 2023Review(s) Completed, Editorial Evaluation Pending
20 Jun 2023Editorial Decision: Accept
